Life Insurance for Scleroderma

Life insurance with scleroderma is attainable — but honestly, your prospects depend almost entirely on which type of scleroderma you have and whether it has affected your internal organs. At Diversified Insurance Brokers, we help people with scleroderma and other autoimmune conditions find the coverage their specific situation allows, and the first thing we tell every applicant is that a scleroderma diagnosis is not a single risk in the eyes of an underwriter — it is a spectrum. Scleroderma is a rare autoimmune connective-tissue disease, estimated to affect roughly 100,000 people in the United States, and it varies enormously from one person to the next. That variability is the whole story when it comes to underwriting. Someone with mild, skin-only localized scleroderma that shows no progression may qualify for a standard rate or better on a traditional term or whole life policy. Someone with diffuse systemic sclerosis affecting the lungs or kidneys faces a much harder path, often a substandard (table-rated) offer, a policy exclusion, or a decline from fully underwritten carriers — with guaranteed issue coverage as the dependable fallback. We will not pretend those two situations are the same. Knowing where you fall on that spectrum, and which carriers view your specific case most fairly, is what determines your outcome.

Because scleroderma affects each patient so differently, simply having the diagnosis is not enough information for an underwriter to make a decision — they will ask detailed questions about your specific type, your symptoms, your organ involvement, your medications, and your disease stability. This is actually good news for well-managed applicants, because it means the diagnosis alone does not doom your application; the details do the deciding, and favorable details produce favorable outcomes. It also means that where you apply matters enormously, because carriers differ significantly in how they underwrite autoimmune connective-tissue disease, and some carriers exclude systemic sclerosis entirely while others will consider it. Applying blindly to the wrong carrier can waste an application and, if declined, place a mark on your shared industry record that makes the next attempt harder. This is why working with an independent broker experienced in high-risk and autoimmune underwriting is so valuable — the same careful, preparation-first approach we bring to life insurance for autoimmune disease generally, and to related conditions like lupus and rheumatoid arthritis, applies directly to scleroderma.

This guide explains how underwriters distinguish between the types of scleroderma, why organ involvement is the pivotal factor, what to realistically expect for rates, the policy options available at every level of severity, and the steps that improve your outcome. The goal is a clear, honest picture — coverage is genuinely available for most people with scleroderma, but the type of coverage and its cost depend on the specifics of your disease.

The Type of Scleroderma Determines Almost Everything

Scleroderma is not one disease but a family of related conditions, and the distinction between them is the single most important factor in how life insurance underwriters evaluate your application. The first and most fundamental split is between localized scleroderma and systemic sclerosis. Localized scleroderma — which includes morphea (patches of thickened skin) and linear scleroderma — primarily affects the skin and the tissue just beneath it. Critically, medical literature indicates that localized scleroderma is not associated with increased mortality and does not involve the internal organs. From an underwriting standpoint, this is the most favorable form: applicants with stable, skin-only localized scleroderma and otherwise good health have a genuine chance at a standard rating, and in the mildest cases even better. Systemic sclerosis is the more serious form, because it affects internal organs — the esophagus and gastrointestinal tract, lungs, heart, and kidneys — in addition to the skin, and it is associated with increased mortality. Systemic sclerosis is itself divided into two forms: limited systemic sclerosis (historically called CREST syndrome, referring to calcinosis, Raynaud’s phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia) and diffuse systemic sclerosis, which involves more widespread and often more rapidly progressing skin and organ involvement. Because systemic sclerosis carries genuine mortality risk, underwriters take it very seriously, and a preferred rating is generally not available for systemic disease — the realistic best case for well-controlled systemic sclerosis is a standard rating, with substandard table ratings being more common. Understanding how to approach life insurance with any significant health condition starts with pinning down exactly which form you have, because the entire underwriting conversation flows from that.

How Underwriters View Scleroderma by Type and Severity

Why Organ Involvement Is the Pivotal Factor

When an underwriter reviews a scleroderma application, the question that matters most is whether — and how severely — the disease has affected your internal organs, because that is what drives mortality risk and therefore the rating. In localized scleroderma, there is no organ involvement, which is precisely why it underwrites so favorably. In systemic sclerosis, the picture depends heavily on which organs are affected and to what degree. Lung involvement is among the most significant concerns; systemic sclerosis can cause pulmonary fibrosis (scarring of the lung tissue) and pulmonary hypertension, both of which materially affect prognosis, which is why applicants with any respiratory involvement should also understand how underwriters approach life insurance with pulmonary conditions. Kidney involvement is another critical factor; scleroderma renal crisis is a rare but historically life-threatening complication, and any kidney involvement raises the stakes of the application considerably, making our guidance on life insurance with kidney disease directly relevant. Heart involvement and severe gastrointestinal complications similarly increase the assessed risk. The practical implication is that your test results — pulmonary function tests, kidney function labs, cardiac evaluations — carry enormous weight in the underwriting decision. An applicant with systemic sclerosis whose organs are not yet affected and whose test results are normal presents a very different risk than one with documented lung scarring or kidney damage, and the two will receive very different offers. This is why comprehensive, current medical documentation from your rheumatologist and specialists is not just helpful but essential to securing the best rating your situation allows. The same organ-focused underwriting logic applies across serious autoimmune conditions, including related connective-tissue diseases like Behçet’s disease.

Have scleroderma and want to know where you realistically stand?
Request a Confidential Pre-Screen of Your Situation

Policy Options at Every Level of Severity

There is a coverage path for nearly everyone with scleroderma, though the right one depends on your type and severity. For those with localized scleroderma or well-controlled limited systemic sclerosis without organ involvement, fully underwritten term life insurance offers the most coverage per dollar and is the goal — a standard or table-rated policy can provide substantial protection at a reasonable cost. No-exam life insurance may be an option for milder, well-documented cases, using accelerated underwriting that draws on prescription and medical databases; some applicants with mild scleroderma can qualify, though carriers still review the full picture. Whole life insurance, which provides permanent coverage and builds cash value, is available at standard or table rates for many applicants and is often used when term is not the priority. For those with systemic sclerosis involving the organs, immunosuppressive treatment, or more advanced disease, fully underwritten coverage may come with significant table ratings or may not be available at all — and this is where guaranteed issue life insurance becomes the dependable path. Guaranteed issue policies ask no health questions and cannot be declined for medical reasons, typically offering smaller face amounts suited to final expenses, usually with a graded death benefit for the first two to three years. It is honest to acknowledge, as members of the scleroderma community themselves report, that some carriers exclude systemic sclerosis and that fully underwritten coverage can be difficult and expensive for advanced disease — which is exactly why knowing the guaranteed issue fallback exists matters, and why matching your case to the right carrier from the start is so important. Our high-risk life insurance playbook lays out how these tiers fit together, and older applicants may also find value in senior coverage designed for health issues or a policy with no medical questions asked.

Steps That Improve Your Outcome

While you cannot change your diagnosis, several concrete steps meaningfully improve the coverage and rate you can secure with scleroderma. Demonstrate disease stability: underwriters look favorably on a documented period without progression, new complications, or organ deterioration, and some carriers extend rating credits when there has been no significant disease activity over an extended period such as five years. Gather comprehensive medical documentation before applying — your rheumatologist’s records, recent pulmonary function tests, kidney and cardiac evaluations, and a clear summary of your type, symptoms, and treatment response give the underwriter the complete, favorable picture and prevent them from assuming the worst in the absence of information. Ask your specialist for a letter summarizing your diagnosis, your specific type, your organ status, and your prognosis, because a treating physician’s confirmation that your disease is stable and localized (or that your organs are unaffected) carries real weight. Manage and document your overall health, since your rating reflects your scleroderma alongside every other health factor and lifestyle choice — being a non-smoker, maintaining healthy metrics, and controlling any other conditions all improve your standing. And above all, apply through a specialist who can pre-screen carriers for your specific type and severity, because the difference between carriers is dramatic for autoimmune connective-tissue disease, and matching your case to a carrier that underwrites it fairly — rather than one that excludes or heavily rates it — is the step that most directly protects your record and secures the best available outcome. Full, honest disclosure is essential throughout: insurers verify information through medical records and shared databases, and an omitted or understated detail can lead to a denied claim later, which would defeat the entire purpose of the coverage. These same principles guide our approach to related conditions such as multiple sclerosis and inflammatory arthritis.

Ready to see real quotes and find carriers that understand scleroderma?
Get Your Personalized Life Insurance Analysis